Integrated transcriptomic and metabolomic analyses revealed that regulation of specialized metabolism in opium poppy is differentiated by organ and stage of development

Opium poppy ( Papaver somniferum L.) is the primary commercial source of benzylisoquinoline alkaloids (BIAs), including the essential analgesics morphine and codeine. Although BIA biosynthesis in capsules has been extensively studied, the spatiotemporal distribution patterns of diverse specialized metabolites across vegetative organs and throughout seed development remain poorly characterized. We generated paired transcriptomic and untargeted metabolomic datasets from S3-stage stems and leaves, and from seeds across five consecutive developmental stages (S1–S5). Multivariate analyses revealed organ identity as the major factor associated with metabolomic variation. Three independent statistical approaches identified the S3–S4 transition as a major developmental interval associated with metabolic reprogramming. Weighted gene co-expression network analysis (WGCNA) resolved 19 co-expression modules, five of which were strongly associated with distinct specialized metabolite classes (| r | > 0.6). Their eigengene expression showed developmental trends, with the largest observed shift occurring between S3 and S4. We annotated 1,295 metabolites, including three core BIAs confirmed by authentic standards (MSI level 1), while most remaining annotations were assigned MSI levels 2–3. These metabolites were characterized across seven major metabolic categories. qRT-PCR confirmed the expression patterns of five candidate genes, including three intramodular candidate hub genes. The coordinated expression of BIA-associated biosynthetic genes and temporal variation of alkaloid relative abundance in developing seeds suggest seed-associated BIA metabolic activity, while contributions from inter-organ transport cannot be excluded. This integrated multi-omics framework provides a systems-level resource for understanding spatiotemporal metabolic organization in P. somniferum and identifies candidate molecular targets for future studies of alkaloid breeding and synthetic biology.